MoneyWorks4Me

Colinz Laboratories - Quaterly Results

30 Oct 2024 Evaluate
A minor change in the total revenue was seen in the September 2024 quarter. The total revenue for the quarter stood at Rs. 18.63 millions against Rs. 17.86 millions during year ago period.Net Profit recorded in the quarter ended September 2024 rise to 27.87% to Rs. 1.56  millions  compared to R. 1.22 millions in corresponding previous quarter.OP of the company witnessed a marginal growth to 2.52 millions from 2.02 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 18.63 17.86 4.31 36.10 36.85 -2.04 70.30 71.55 -1.75
Other Income 0.78 0.76 2.63 1.45 1.20 20.83 2.75 1.72 59.88
PBIDT 2.52 2.02 24.75 4.78 3.97 20.40 8.17 7.81 4.61
Interest 0.12 0.09 33.33 0.21 0.17 23.53 0.37 0.52 -28.85
PBDT 2.40 1.93 24.35 4.57 3.80 20.26 7.80 7.29 7.00
Depreciation 0.32 0.33 -3.03 0.64 0.66 -3.03 1.30 1.29 0.78
PBT 2.08 1.60 30.00 3.93 3.14 25.16 6.50 6.00 8.33
TAX 0.52 0.38 36.84 1.00 0.70 42.86 1.64 1.42 15.49
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.12 -0.16 -25.00
PAT 1.56 1.22 27.87 2.93 2.44 20.08 4.86 4.58 6.11
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 13.53 11.31 19.60 13.24 10.77 22.90 11.62 10.92 6.47
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..